Completed NA INTERVENTIONAL NCT00407004

Elimination of Albumin-Bound Substances by MARS and Prometheus

Effect of Extracorporeal Liver Support by MARS and Prometheus on Albumin-Bound Substances in Acute-on-Chronic Liver Failure

Sponsor: Fresenius Medical Care North America

Conditions Liver Failure

Interventions MARS (Molecular Adsorbents Recirculating System) Prometheus (FPSA, Fractionated Plasma Separation and Adsorption)

Updated 5 times since 2017 Last updated: Dec 1, 2006 Started: Mar 31, 2003 Completion: Apr 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Liver Failure and is currently completed. Fresenius Medical Care North America leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fresenius Medical Care North America
Medical University of Graz

Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Graz, Austria